medindia

Glucagon Used Less Often in Pre-hospital and Outpatient Setting

by Hannah Joy on  December 26, 2017 at 5:47 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Glucagon, a hormone that helps hypoglycemic complications was found to be underutilized by emergency medical personnel and underprescribed to patients, reveals a new study.

A brief research report is published in Annals of Internal Medicine.
Glucagon Used Less Often in Pre-hospital and Outpatient Setting
Glucagon Used Less Often in Pre-hospital and Outpatient Setting


Researchers from Harvard Medical School reviewed data from the National Emergency Medical Services Information System (MEMSIS) Public-Release Research Datasets from 2013 to 2015 and from Medicare Part D claims from 2014 to characterize glucagon use and availability in the pre-hospital and outpatient setting.

Show Full Article




They found that glucagon is underutilized by emergency medical personnel and underprescribed to patients.



According to the researchers, prescribing glucagon to patients could effectively reduce pre-hospital hypoglycemic complications.



They also suggest that all emergency personnel nationwide should have access to glucagon along with training to safely administer it.



Ensuring this access could reduce morbidity, mortality, and healthcare costs.





Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Most Popular On Medindia:

Find a Doctor

Find a Doctor

Sanatogen

Sanatogen

How to Reduce School Bag Weight - Simple Tips

How to Reduce School Bag Weight - Simple Tips

Recommended Reading

Appetite Hormone Glucagon Fails to Work in Obese People

Glucagon, a hormone involved in regulating appetite, is unable to help obese people feel full after a meal, but it continues to suppress hunger pangs in people with type 1 diabetes.

Glucagon-Like Peptide-1 Receptor Agonists Related to Adolescent Weight Loss Suggests Study

Preliminary evidence from a clinical trial suggests that treatment with GLP-1 receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity.

GLP-1 Hormone Deficiency in the Brain may Result into Binge Eating

By finding out how the central nervous system regulates food intake via GLP-1 signaling, we may be able to provide more targeted therapy with fewer side effects.

Drugs That Target Hormones Help in Weight Loss

Two different drug classes that target different hormones: amylin and glucagon-like peptide-1 helps in weight loss.

More News on:

Pancreas

What's New on Medindia

New Cancer Atlas Indicates that Progress in Fighting Cancer is Possible and Achievable

Drugs and Cosmetics Rules - Schedule H & Schedule H1 Drugs

Hypertension / High Blood Pressure
View All

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive